Add To Watchlist
Share URL
GSK plc
GSK.L: LSELowest reading is at 11 out of 100. All scores are out of 100.
In Short
About The Company
CEO
Mr. Luke Victor Miels
Market Cap
74.14 Billion GBp
Sector
Healthcare
Website
https://www.gsk.comLast Update
27/09/2026, 17:13:43
Description
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
Read More
Strongest readings
- ✔Return on capital employed of 19.97% is above the market average of 10.00%
- ✔Financial health is strong (health score 61 out of 100)
Weakest readings
- ✘Revenue is growing at 3.46% per year while free cashflow is falling
- ✘Earnings and cashflow growth is weak (growth score 11 out of 100)
- ✘The current price sits above estimated fair value (margin of safety -61.93%)
- ✘Short-term liabilities exceed short-term assets (current ratio 0.82)
- ✘Share count has been rising at 0.35% per year
Key Figures
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
Price / earnings (TTM) | N/A | 19.60x | ||
| ✘ | Margin of safety (DCF) | -61.93% | 17.95% | |
| ✘ | Revenue growth (5y average) | 3.46% | 10.97% | |
| ✔ | Dividend yield (TTM) | 3.60% | 1.85% | |
| ✘ | Share count, per year | 0.35% | 0.00% | |
| ✔ | Return on capital employed | 19.97% | 10.00% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Valuation
81 / 100Priced at or below the market on most measures.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
Price / earnings | N/A | 19.60x | ||
| ✔ | Free cashflow yield | 7.19% | 4.70% | |
| Price / earnings growth | N/A | 1.50x | ||
| Price / book | 431.65x | — | ||
| ✘ | Margin of safety | -61.93% | 17.95% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✘Estimated intrinsic value of 704.67 GBp is below the current price of 1.85 Thousand GBp
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Estimated Fair Value: 24.1 GBp ✘
Current Price: 1851 GBp
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated fair value for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel for the impact this has on longterm investment returns and find a margin of safety you are comfortable with.
Growth
11 / 100Growing more slowly than the market on most measures.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Revenue growth | 3.46% | 10.97% | |
| ✘ | Earnings growth | -24.10% | 14.48% | |
| ✘ | Cashflow growth | -6.04% | 12.35% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✘Revenue is growing at 3.46% per year while free cashflow is falling at 6.04% per year
Health
61 / 100Balance sheet covers its obligations.
Measured on Leverage and capital, Funding and liquidity, Earnings quality.
| Status | Metric | Value | Reading | Threshold |
|---|---|---|---|---|
| ✘ | Altman-Z score | 1.13 | 3.00 | |
| ✔ | Piotroski score | 9.00 | 5.00 | |
| ✘ | Debt / equity | 1.08x | 0.80x | |
| ✘ | Current ratio | 0.82x | 1.00x | |
| ✔ | Interest coverage | 11.32x | 2.50x | |
| ✔ | Free cashflow / debt | 0.36x | 0.15x | |
| ✔ | Debt / capital | 0.52x | 1.00x |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Dividend
53 / 100Covered, with limited headroom.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✔ | Dividend yield | 3.60% | 1.85% | |
| ✔ | Dividend growth | 4.91% | 0.00% | |
| ✘ | Payout ratio (earnings) | 55.30% | 40.00% | |
| ✔ | Payout ratio (cashflow) | 50.01% | 65.00% | |
| ✘ | Worst year, last 5 years | -35.60% | -2.00% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✔Dividend growth has been accelerating recently
- ✘The dividend was cut within the last five years (worst year -35.60% per share)
Management
62 / 100Returns on capital are at or above the market.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✔ | Return on equity | 34.90% | 15.00% | |
| ✔ | Return on capital employed | 19.97% | 10.00% | |
| Return on assets | 9.35% | — | ||
| Free cashflow return on capital | 16.09% | — | ||
| ✔ | Return on capital, 5y change | 6.25% | 0.00% | |
| ✘ | Share count, per year | 0.35% | 0.00% | |
| ✔ | Share count, recent | -1.12% | 0.00% | |
| ✘ | Realized buyback return | -65.05% | 0.00% | |
| ✘ | Goodwill erosion / equity | 23.12% | 2.00% | |
| Price volatility, 5 year | 21.81% | — |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✘New shares were issued while the value score was 81 out of 100
- ✔Dividends were reduced when earnings fell (dividend -4.20% per year, earnings -24.10% per year)
Analysts
not enough data| Status | Metric | Value | Reading | Neutral |
|---|---|---|---|---|
| Analyst opinion score | N/A | 50 |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Financial History
Annual figures across the full reporting history we hold.
Market Peers
GSK.L
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
See 35+ Years Annual ReportsOther Information
Company Name
GSK plc
Currency
GBp
Beta
0.29
Vol Avg
7008285
Ceo
Mr. Luke Victor Miels
Cik
Cusip
Exchange
LSE
Full Time Employees
66841
Industry
Drug Manufacturers - General
Sector
Healthcare
Ipo Date
Address
79 New Oxford Street
City
London
State
Country
United Kingdom
Zip
WC1A 1DG
Phone
44 20 8047 5000
Analysis Last Updated
27/09/2026, 17:13:43
Financial data compiled from SEC EDGAR filings and Yahoo Finance.